Title Category Credit Event date Cost
Current and Future Applications of Gene Therapy
  • Disease Management
  • ACPE - Pharmacist
  • ACPE - Pharmacy Technician
  • AMA
  • ANCC
  • Attendance
  • CCMC - General
$0.00 Gene therapy involves altering the genes inside the body's cells in an effort to treat or stop disease. Either a faulty gene is replaced or a new gene is added in an attempt to cure disease or improve the body's ability to fight disease. Important medical advances in gene therapy have been achieved during the past few years, with clinical translational trials underway for a wide range of deadly diseases.
Diabetes: Improvements in Prevention and Care
  • Disease Management
  • ACPE - Pharmacist
  • ACPE - Pharmacy Technician
  • AMA
  • ANCC
  • Attendance
  • CCMC - General
$0.00 In the United States, an estimated 86 million people are living with prediabetes and 29 million are living with diabetes. Lifestyle management is a fundamental aspect of diabetes care. There is strong and consistent evidence that obesity management can delay the progression of diabetes, and screening and interventions can limit organ damage. Therefore, diabetes patients require initial and ongoing evaluation for diabetes and its related complications.
Advances in CAR T-Cell Immunotherapy in Leukemia
  • Oncology
  • ACPE - Pharmacist
  • ACPE - Pharmacy Technician
  • AMA
  • ANCC
  • Attendance
  • CCMC - General
$0.00 Chimeric antigen receptor (CAR) T-cell therapy continues to have impressive showings in patients with aggressive hematologic malignancies with no other promising treatment options. This session will discuss outcomes when using T-cell immunotherapy against relapsed or refractory acute lymphoblastic leukemia (ALL).Learning ObjectivesAt the end of this educational activity, participants should be able to:
Predicting Risk: Current Research and New Therapies for Optimal Management of Colorectal Cancer
  • Oncology
  • ACPE - Pharmacist
  • ACPE - Pharmacy Technician
  • AMA
  • ANCC
  • Attendance
  • CCMC - General
$0.00 Colorectal cancer is a leading cause of cancer-related deaths in the United States. Research is always going on in this area of medicine, leading to great progress in recent discoveries of new and improved treatment and screening strategies. Tests have been developed to find genetic changes associated with colorectal cancer and to predict the risk of cancer recurrence. Identifying these genes can help doctors and individuals decide on their treatment options to extend survival and improve quality of life.
Increasing Living Donation in Minorities: Special Focus on Hispanics
  • Transplantation
  • ACPE - Pharmacist
  • ACPE - Pharmacy Technician
  • AMA
  • ANCC
  • Attendance
  • CCMC - General
$0.00 For Hispanic/Latino individuals, not having a Spanish-speaking health care professionals to help guide them through the transplant process can mean unnecessary suffering and even death. Having a transplant program tailored for the Hispanic and Latino communities with a bilingual team of surgeons, nurses, social workers, transplant specialists, and support staff can make life-saving surgeries more accessible by removing cultural and linguistic barriers.
Integrating Telemedicine into Health Care Delivery for the Transplant Population
  • Transplantation
  • ACPE - Pharmacist
  • ACPE - Pharmacy Technician
  • AMA
  • ANCC
  • Attendance
  • CCMC - General
$0.00 Telemedicine has continued to grow as a unique way of delivering care to patients, while greatly improving access, reducing cost and positively impacting quality. Dr. Mulligan has been incorporating telehealth in the form of videoconferencing into the transplant setting, thus saving patients the effort of traveling to their follow-up appointments, taking time off work and avoiding potential exposure to other patients while they have a weakened immune system. With a focus on patients that undergo transplantation, Dr.
Metabolic Surgery and Transplantation
  • Transplantation
  • ACPE - Pharmacist
  • ACPE - Pharmacy Technician
  • AMA
  • ANCC
  • Attendance
  • CCMC - Ethics
$0.00 Obesity in transplantation has become prevalent and presents a difficult dilemma for transplant programs. Many transplant centers consider obesity a relative contraindication for transplant due to the associated risks of surgical complications. There are limited clinical alternatives for the management of obesity in the transplant patient other than metabolic surgery, diet and exercise. This activity will discuss the safety and efficacy of metabolic surgery, including the sustainability of weight control over the long term and its effect on posttransplant weight gain.
Sickle Cell Disease: Panel Discussion
  • Transplantation
  • ACPE - Pharmacist
  • ACPE - Pharmacy Technician
  • AMA
  • ANCC
  • Attendance
  • CCMC - General
$0.00 Sickle cell disease (SCD) is the most common inherited hemoglobin disorder, affecting 70,000–100,000 people in the U.S. Allogeneic hematopoietic stem cell transplant (HSCT) is currently the only curative treatment for severe SCD that offers excellent long-term survival, but access is limited for several reasons, including donor availability, as well as sociocultural and economic barriers.
The Impact of Frailty on Posttransplant Outcomes
  • Transplantation
  • ACPE - Pharmacist
  • AMA
  • ANCC
  • Attendance
  • CCMC - Ethics
$0.00 Frailty impacts various general aspects of health care and, in particular, organ transplantation, including patient selection, waitlist management and treatment posttransplant. In general, frailty has been characterized by a compromised physiological reserve. In comparison to healthy aging, inflammatory markers and cytokines are increased in frail older adults. Thus, modifications of the immune response, in addition to physical limitations and changes of metabolism, are likely to impact outcomes after transplantation.
Transitioning from Pediatric to Adult Transplant Care for Solid Organ Transplants
  • Pediatrics
  • Transplantation
  • ACPE - Pharmacist
  • ACPE - Pharmacy Technician
  • AMA
  • ANCC
  • Attendance
  • CCMC - General
$0.00 The transition of health care for adolescents with solid organ transplants as they move into adult-centered services has become more significant over recent years as survival has improved. Since the transfer process from pediatric to adult care can be a challenging phase for transplant recipients, their families, and providers, transition planning should begin at an early age and be an integral component of their ongoing care. This activity will address the potential challenges and psychosocial factors associated with transitioning from pediatric to adult transplant care.

Pages